We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-3.4%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+505.55%
AUM
$396B
AUM Growth
-$4.47B
Cap. Flow
+$17.3B
Cap. Flow %
4.36%
Top 10 Hldgs %
17.57%
Holding
6,885
New
459
Increased
2,707
Reduced
2,368
Closed
646

Sector Composition

Rank Sector Weight
1 Technology 15.47%
2 Healthcare 9.44%
3 Financials 9.02%
4 Consumer Discretionary 7.88%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASRT
5601
DELISTED
Assertio
ASRT
$82K ﹤0.01%
2,419
-4,220
-64% -$191K
PASG icon
5602
Passage Bio
PASG
$14.1M
$82K ﹤0.01%
3,292
-1,824
-36% -$71.9K
GPGI
5603
GPGI Inc
GPGI
$4.34B
$81K ﹤0.01%
+19,551
New +$91.6K
SABA
5604
Saba Capital Income & Opportunities Fund II
SABA
$224M
$81K ﹤0.01%
+9,991
New +$90.4K
MLTX icon
5605
MoonLake Immunotherapeutics
MLTX
$1.53B
$79K ﹤0.01%
10,210
-1,575
-13% -$11.1K
MRAM icon
5606
Everspin Technologies
MRAM
$367M
$79K ﹤0.01%
+13,724
New +$87.4K
ATTO
5607
DELISTED
Atento S.A.
ATTO
$79K ﹤0.01%
19,493
-100
-0.5% -$642
BRCC icon
5608
BRC Inc
BRCC
$241M
$78K ﹤0.01%
10,096
-69,015
-87% -$624K
ARVL
5609
DELISTED
Arrival Ordinary Shares
ARVL
$78K ﹤0.01%
1,929
+1,481
+331% +$97.6K
RNERW
5610
DELISTED
Mount Rainier Acquisition Corp. Warrant
RNERW
$77K ﹤0.01%
514,688
PHX
5611
DELISTED
PHX Minerals
PHX
$76K ﹤0.01%
23,490
-24,546
-51% -$79.1K
VOR icon
5612
Vor Biopharma
VOR
$1.28B
$76K ﹤0.01%
953
-424
-31% -$41.7K
VRA icon
5613
Vera Bradley
VRA
$96.1M
$76K ﹤0.01%
25,240
-120,688
-83% -$486K
PYR
5614
DELISTED
PyroGenesis Canada Inc. Common Shares
PYR
$76K ﹤0.01%
68,575
-5,354
-7% -$8.06K
CPSS icon
5615
Consumer Portfolio Services
CPSS
$208M
$75K ﹤0.01%
10,299
-7,878
-43% -$90.5K
GRCL
5616
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$75K ﹤0.01%
23,319
-959
-4% -$3.12K
ATNM icon
5617
Actinium Pharmaceuticals
ATNM
$24.7M
$74K ﹤0.01%
+10,055
New +$62.5K
BBAR icon
5618
BBVA Argentina
BBAR
$3.56B
$74K ﹤0.01%
+24,503
New +$68.4K
RETL icon
5619
Direxion Daily Retail Bull 3X ETF
RETL
$28.9M
$74K ﹤0.01%
12,018
XOS icon
5620
Xos
XOS
$36.1M
$74K ﹤0.01%
2,060
+463
+29% +$23.7K
PVLA
5621
Palvella Therapeutics
PVLA
$2.23B
$74K ﹤0.01%
809
-185
-19% -$23.9K
AAOI icon
5622
Applied Optoelectronics
AAOI
$9.97B
$73K ﹤0.01%
26,940
-149,954
-85% -$338K
SSKN
5623
DELISTED
Strata Skin Sciences
SSKN
$73K ﹤0.01%
8,419
-11,440
-58% -$116K
AMYT
5624
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$73K ﹤0.01%
10,609
-684
-6% -$5.1K
HIX
5625
Western Asset High Income Fund II
HIX
$353M
$72K ﹤0.01%
+16,600
New +$87.8K

Similar funds

Goldman Sachs's Q3 2022 Portfolio in Review

As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.

  • Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
  • Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
  • Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
  • Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
  • Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
  • Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
  • Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.